Search results for "SoMe"

showing 10 items of 5114 documents

Theoretical and experimental evaluation of decypolyglucoside vesicles as potential drug delivery systems

2006

The aim of this work was to ascertain the capability of a commercial mixture of decylpolyglucoside (Orami.x NS10) to form vesicle structures in water, either alone or in association with cholesterol. To this purpose, we compared results obtained from a theoretical model with those acquired from the experimental characterization of different Orami.x NS10/cliolesterol mixtures. The germen vesicular formation theory was used to predict the formation process of vesicular structures. To this purpose, the energy balance involved in the vesicle formation was calculated using critical concentration for vesicle formation (ccf), surface tension and molecular area of decylpolyglucoside. The ccf was me…

Surface tensionPolarized light microscopyPulmonary surfactantDynamic light scatteringChemistryVesicleTensiometer (surface tension)Analytical chemistryPharmaceutical ScienceNiosomeDrug carrierJournal of Drug Delivery Science and Technology
researchProduct

Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavage.

2009

The topoisomerase I inhibitor topotecan (TPT) is used in the therapy of different tumors including high-grade gliomas. We previously showed that TPT-induced apoptosis depends on p53 with p53 wild-type (wt) cells being more resistant because of p53-controlled degradation of topoisomerase I. Here, we show that p53-deficient (p53(-/-)) fibroblasts undergo excessive mitochondrial apoptosis featuring H2AX phosphorylation, Bcl-x(L) decline, cytochrome c release, caspase-9/-3/-2 activation, and cleavage of Bid. In wt and apaf-1(-/-) cells, caspase-2 did not become activated and Bid was not cleaved. In addition, p53(-/-) cells cotreated with TPT and caspase-3 inhibitor showed neither caspase-2 acti…

SurvivinBlotting WesternDown-RegulationCaspase 3ApoptosisX-Linked Inhibitor of Apoptosis ProteinBiologyTopoisomerase-I InhibitorInhibitor of apoptosisTransfectionInhibitor of Apoptosis ProteinsHistonesMiceCell Line TumorSurvivinAnimalsHumansPhosphorylationRNA Small InterferingPharmacologyMice KnockoutCaspase 3Caspase 2TransfectionFibroblastsFlow CytometryMolecular biologyXIAPMice Inbred C57BLRepressor ProteinsApoptotic Protease-Activating Factor 1ApoptosisCancer researchMolecular MedicineApoptosomeTopoisomerase I InhibitorsTumor Suppressor Protein p53TopotecanMicrotubule-Associated ProteinsBH3 Interacting Domain Death Agonist ProteinThe Journal of pharmacology and experimental therapeutics
researchProduct

Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism.

2014

Background Chronic myeloid leukemia (CML) is a clonal hematopoietic stem cell disorder in which leukemic cells display a reciprocal t(9:22) chromosomal translocation that results in the formation of the chimeric BCR-ABL oncoprotein, with a constitutive tyrosine kinase activity. Consequently, BCR-ABL causes increased proliferation, inhibition of apoptosis, and altered adhesion of leukemic blasts to the bone marrow (BM) microenvironment. It has been well documented that cancer cells can generate their own signals in order to sustain their growth and survival, and recent studies have revealed the role of cancer-derived exosomes in activating signal transduction pathways involved in cancer cell…

SurvivinMice NudeMice SCIDBiologyAutocrine mechanismsExosomesBiochemistryExosomeInhibitor of Apoptosis ProteinsTransforming Growth Factor beta1Micehemic and lymphatic diseasesCell Line TumorLeukemia Myelogenous Chronic BCR-ABL PositiveTGF-β1medicineAnimalsHumansAutocrine signallingMolecular BiologyCell ProliferationTumor microenvironmentCell growthResearchChronic myeloid leukemiaMyeloid leukemiaCell Biologymedicine.diseaseMicrovesiclesCML exosomesCell biologyNeoplasm ProteinsLeukemiaAutocrine CommunicationCancer cellAnti-apoptotic pathwaysApoptosis Regulatory ProteinsSignal TransductionCell communication and signaling : CCS
researchProduct

Karyopherin Msn5 is involved in a novel mechanism controlling the cellular level of cell cycle regulators Cln2 and Swi5

2019

ABSTRACT The yeast β-karyopherin Msn5 controls the SBF cell-cycle transcription factor, responsible for the periodic expression of CLN2 cyclin gene at G1/S, and the nuclear export of Cln2 protein. Here we show that Msn5 regulates Cln2 by an additional mechanism. Inactivation of Msn5 causes a severe reduction in the cellular content of Cln2. This occurs by a post-transcriptional mechanism, since CLN2 mRNA level is not importantly affected in asynchronous cultures. Cln2 stability is not significantly altered in msn5 cells and inactivation of Msn5 causes a reduction in protein level even when Cln2 is stabilized. Therefore, the reduced amount of Cln2 in msn5 cells is mainly due not to a higher …

Swi50301 basic medicineSaccharomyces cerevisiae ProteinsS. cerevisiaeCell Cycle ProteinsSaccharomyces cerevisiaeKaryopherinsCell cycleBiologyProtein degradationCyclin Gene03 medical and health sciences0302 clinical medicineCyclinsGene Expression Regulation FungalPolysomeProtein biosynthesisNuclear export signalMolecular BiologyTranscription factorCyclinMsn5 karyopherinCell BiologyCell cycleActinsCell biologyCln2 cyclin030104 developmental biologyMutagenesisPolyribosomesProtein Biosynthesis030220 oncology & carcinogenesisTranscription FactorsResearch PaperDevelopmental BiologyCell Cycle
researchProduct

Subcellular localization and characterization of nitric oxide synthase(s) in endothelial cells: physiological implications.

1994

Endothelial cells (EC) contain a constitutive Ca2+/calmodulin-dependent nitric oxide (NO) synthase (cNOS) which plays an important role in the local control of vascular tone. We compared the subcellular distribution of this enzyme in cultured and freshly isolated pig EC by determination of specific cNOS activity and immunoblot analysis. Similar studies were also performed with cultured and freshly isolated bovine and cultured human EC. Enzyme activity was predominantly (> 70%) associated with the particulate fraction of all EC types tested and was highest in freshly isolated porcine EC. Both specific cNOS activity and immunoreactivity were substantially higher (> 3-fold) in th…

SwineBiochemistryNitric oxidechemistry.chemical_compoundMicrosomesAnimalsHumansMolecular BiologyCells CulturedAmino acid oxidoreductaseschemistry.chemical_classificationbiologyATP synthaseCell BiologyEnzyme assayBiomechanical PhenomenaUp-RegulationNitric oxide synthaseEndothelial stem cellEnzymechemistryBiochemistrybiology.proteinCattleAmino Acid OxidoreductasesEndothelium VascularCell fractionationNitric Oxide SynthaseResearch ArticleThe Biochemical journal
researchProduct

Transcutol containing vesicles for topical delivery of minoxidil

2010

The aim of this work was to evaluate the ability of Transcutol (Trc) to produce elastic vesicles with soy lecithin (SL) and study the influence of the obtained vesicles on in vitro (trans)dermal delivery of minoxidil. To this purpose, so-called penetration enhancer-containing vesicles (PEVs) were prepared using Trc aqueous solutions (5-10-20-30% v/v) as hydrophilic phase. SL liposomes, without Trc, were used as control. Prepared formulations were characterized in terms of size distribution, morphology, zeta potential, deformability, and rheological behavior. The influence of the obtained PEVs on (trans)dermal delivery of minoxidil was studied by in vitro diffusion experiments through pig sk…

SwineStereochemistryVasodilator AgentsPharmaceutical ScienceAdministration CutaneousDiffusionExcipientschemistry.chemical_compoundDrug Delivery SystemsDrug Stabilitystomatognathic systemPhosphatidylcholineLecithinsZeta potentialmedicineAnimalsParticle SizeMicroparticleSkinDrug CarriersLiposomeAqueous solutionChromatographyChemistryVesiclefungiPenetration (firestop)MinoxidilLiposomesMinoxidilEthylene Glycolsmedicine.drugJournal of Drug Targeting
researchProduct

Phylogenetic analysis of the thiolase family. Implications for the evolutionary origin of peroxisomes

1992

The thiolase family is a widespread group of proteins present in prokaryotes and three cellular compartments of eukaryotes. This fact makes this family interesting in order to study the evolutionary process of eukaryotes. Using the sequence of peroxisomal thiolase from Saccharomyces cerevisiae recently obtained by us and the other known thiolase sequences, a phylogenetic analysis has been carried out. It shows that all these proteins derived from a primitive enzyme, present in the common ancestor of eubacteria and eukaryotes, which evolved into different specialized thiolases confined to various cell compartments. The evolutionary tree obtained is compatible with the endosymbiotic theory fo…

SymbiogenesisMolecular Sequence DataSequence alignmentSaccharomyces cerevisiaeBiologyMicrobodiesHomology (biology)PhylogeneticsMolecular evolutionGeneticsAmino Acid SequenceAcetyl-CoA C-AcetyltransferaseSymbiosisThiolaseMolecular BiologyGenePhylogenyEcology Evolution Behavior and SystematicsGeneticsPhylogenetic treeThiolasePeroxisome evolutionBiological EvolutionEvolutionary biologyBootstrap analysisSequence Alignment
researchProduct

The role of lipid rafts in vesicle formation

2023

ABSTRACT The formation of membrane vesicles is a common feature in all eukaryotes. Lipid rafts are the best-studied example of membrane domains for both eukaryotes and prokaryotes, and their existence also is suggested in Archaea membranes. Lipid rafts are involved in the formation of transport vesicles, endocytic vesicles, exocytic vesicles, synaptic vesicles and extracellular vesicles, as well as enveloped viruses. Two mechanisms of how rafts are involved in vesicle formation have been proposed: first, that raft proteins and/or lipids located in lipid rafts associate with coat proteins that form a budding vesicle, and second, vesicle budding is triggered by enzymatic generation of cone-sh…

Synaptic vesiclesRaftsMembraneEnveloped virusTransport vesiclesCell BiologyExtracellular vesiclesExosomesEndocytic vesiclesJournal of Cell Science
researchProduct

Thirty years of synaptosome research.

1993

Detached synapses (synaptosomes), first isolated by the author in 1958 and identified as such in 1960, are sealed presynaptic nerve terminals often with a portion of the target cell--sometimes amounting to a complete dendritic spine--adhering to their external surface. They can be prepared in high yield from brain tissue and also in decreasing yield from spinal cord, retina, sympathetic ganglia, myenteric plexus and electric organs. They are sealed structures which, under metabolizing conditions, respire, take up oxygen and glucose, extrude Na+, accumulate K+, maintain a normal membrane potential and, on depolarization, release transmitter in a Ca(2+)-dependent manner. They thus provide an …

SynaptosomeNervous systemMembrane potentialNeurotransmitter AgentsHistologyDendritic spineGeneral NeuroscienceResearchModels NeurologicalDepolarizationCell BiologyBiologySynaptic vesicleSynapsemedicine.anatomical_structureSynapsesmedicineBiophysicsCentrifugation Density GradientAnimalsAnatomyNeuroscienceMyenteric plexusSynaptosomesJournal of neurocytology
researchProduct

A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral i…

2005

Synthetic vaccineT cellMolecular Sequence DataEpitopes T-LymphocyteCancer VaccinesCatalysisEpitopeImmune systemAntigenAntibody SpecificityAntigens NeoplasmmedicineCarbohydrate ConformationVaccines SyntheticChemistryMucin-1GlycopeptidesModels ImmunologicalStereoisomerismGeneral ChemistryGlycopeptidemedicine.anatomical_structureCarbohydrate SequenceImmunologyAntibody FormationSynthetic immunologyAngewandte Chemie (International ed. in English)
researchProduct